📰 Recurrence Score News
Page 3 - Recurrence Score News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Recurrence Score. Real-time updates on events, politics, business and more.
January 5, 2023
Scores on a breast recurrence assay may signal which patients can get neoadjuvant endocrine therapy vs chemotherapy. The study was published as a preprint and has not yet been peer reviewed.
December 9, 2022
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today shared initial clinical validation data...
December 7, 2022
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations...
December 7, 2022
New independent clinical evidence from the pivotal TAILORx and RxPONDER trials support the role of the Oncotype DX Breast Recurrence Score test, the only genomic test to predict chemotherapy
December 6, 2022
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations...
October 1, 2022
How one woman is using her journey with the disease—and her experience with the Oncotype DX Breast Recurrence Score test—to help others.
September 22, 2022
Investors should consider buying these Nasdaq stocks on the dip while they still can before the market reverses higher.
August 11, 2022
Phase 2 BRACELET-1 trial fully enrolled and advancing towards a randomized data readout that is expected to inform the design of a registrational study in...
August 11, 2022
Phase 2 BRACELET-1 trial fully enrolled and advancing towards a randomized data readout that is expected to inform the design of a registrational study in HR+/HER2- breast cancer Achieved
August 3, 2022
ADAPT Triad minimal residual disease analysis study intended to evaluate the association between circulating tumor DNA (ctDNA) positivity and recurrence intervals MADISON, Wis., Aug. 3